Cardiovascular disease is a global epidemic and COVID-19 is a pandemic within that epidemic

Cardiovascular Disease and COVID-19
CardioPharma Responds to COVID-19
- PRESS RELEASE 30 MAR 20 CardioPharma Responds to COVID-19
To receive the latest CardioPharma and COVID-19 News
Helpful information sources on COVID-19:
Cardiology
Publications and Podcasts
- 21 Oct 20 IARS, Chow, et. al. “Aspirin Use is Associated with Decreased Mechanical Ventilation, ICU Admission, and In-Hospital Mortality in Hospitalized Patients with COVID-19“
- 24 Aug 20 CAR, Baral, et. al. “Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 Patients“
- 28 Jul 20 IJM, Alegbeleye, et. al. “The Novel Aspirin as Breakthrough Drug for COVID-19 A Narrative Review“
- 27 Jul 20 Clin and Exp Med, Gavriatopoulou, et al. “Organ-specific manifestations of COVID-19 infection“
- 17 Jul 20 MMWR, Wortham, et. al. “Characteristics of Persons Who Died with COVID19 United States February 12 to May 18 2020” (On July 10, 2020, this report was posted online as an MMWR Early Release. Please note: This report has been corrected.)
- 13 Jul 20 BMJ Heart, Hippisley-Cox, et. al. “Risk of sever COVID-19 disease with ACE inhibitors and angiotensin receptor blockers Cohort study including 8.3 million people“
- 15 Jun 20 Lancet, Clark, et. al. “Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study“
- 15 Jun 20 MMWR, Stokes, et. al. “Coronavirus Disease 2019 Case Surveillance — United States, January 22–May 30, 2020“
- 1 May 20 NEJM, Mehra, et. al. “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19“
- 22 Apr 20 JAMA, Richardson, et. al. “Presenting Characteristics Comorbidities and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area”
- 6 APR 20 JAMA, Garcelli, et. al. ”Baseline Characteristics and Outcomes of 1591 Patients infected with SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy” (note Table 1)
- 26 Mar 20 Imperial College London, Walker, et. al. “The Global Impact of COVID-19 and Strategies for Mitigation and Suppression“
- 20 Mar 20 BMJ, Heart Podcast “COVID-19 in Seattle – hope for the best, prepare for the worst“
- 18 Mar 20 EHJ, Xiong, et. al. “Coronaviruses and the cardiovascular system“
- 17 Mar 20 JACC, Driggin, et. al. “Cardiovascular Considerations…During the Pandemic“
- 17 Mar 20 Italian Dept of Health “Characteristics of Deceased and Positive COVID-19 Patients in Italy“
- 16 Mar 20 JAMA, Hopman, et. al. “Managing COVID-19 in Low and Middle Income Countries“
- 13 Mar 20 ACC “Heart Patients Warned of Risks from Coronavirus“
- 12 Mar 20 IJID, Yang, et. al. “Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection“
- 9 Mar 20 Lancet, Zhou, et. al. “Clinical course and risk factors for mortality of adult inpatients with COVID-19…“
- 24 Jan 20 Lancet, Huang, et. al. “Clinical features of patients infected with 2019 novel coronavirus“